Paper4321663
Multiple cyclic nucleotide phosphodiesterase activities from rat brain.
Thompson WJ and 1 other. Biochemistry, 1971. Cited by 1,299 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Papers, record 4321663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4321663
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Phosphoric Monoester Hydrolases | Major topic |
| Animals | |
| Chromatography, Gel | |
| Cyclic AMP | |
| Guanine Nucleotides | |
| Kinetics | |
| Mathematics | |
| Rats | |
| Tritium |
Source PubMed
Cited by251
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,299 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,659,490 | The rewiring of cAMP/cGMP and LDH signalling drives cardiac hypertrophy in Pde5a -/- mice. | Life Sci Alliance | 2025 | https://conductscience.org/library/papers/40659490 | PubMed |
| 40,081,105 | Cyclic nucleotide phosphodiesterases as drug targets. | Pharmacol Rev | 2025 | https://conductscience.org/library/papers/40081105 | PubMed |
| 39,895,533 | Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure. | J Am Heart Assoc | 2025 | https://conductscience.org/library/papers/39895533 | PubMed |
| 36,674,621 | Structural Characterization of Murine Phosphodiesterase 5 Isoforms and Involvement of Cysteine Residues in Supramolecular Assembly. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36674621 | PubMed |
| 35,955,722 | Cellular Redox Metabolism Is Modulated by the Distinct Localization of Cyclic Nucleotide Phosphodiesterase 5A Isoforms. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35955722 | PubMed |
| 35,338,117 | Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder. | Transl Psychiatry | 2022 | https://conductscience.org/library/papers/35338117 | PubMed |
| 34,062,786 | Phosphodiesterase 4D Depletion/Inhibition Exerts Anti-Oncogenic Properties in Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34062786 | PubMed |
| 33,807,511 | Phosphodiesterases Expression during Murine Cardiac Development. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33807511 | PubMed |
| 33,659,551 | Measuring cAMP Specific Phosphodiesterase Activity: A Two-step Radioassay. | Bio Protoc | 2020 | https://conductscience.org/library/papers/33659551 | PubMed |
| 32,898,611 | Milestones in the development and implementation of FRET-based sensors of intracellular signals: A biological perspective of the history of FRET. | Cell Signal | 2020 | https://conductscience.org/library/papers/32898611 | PubMed |
| 32,221,940 | Methods to Investigate Signal Transduction Pathways in Trypanosoma cruzi: Cyclic Nucleotide Phosphodiesterases Assay Protocols. | Methods Mol Biol | 2020 | https://conductscience.org/library/papers/32221940 | PubMed |
| 31,817,312 | Effects of Synergistic Inhibition on α-glucosidase by Phytoalexins in Soybeans. | Biomolecules | 2019 | https://conductscience.org/library/papers/31817312 | PubMed |
| 31,147,439 | A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease. | Haematologica | 2020 | https://conductscience.org/library/papers/31147439 | PubMed |
| 30,825,186 | Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells. | Br J Pharmacol | 2019 | https://conductscience.org/library/papers/30825186 | PubMed |
| 29,847,860 | The phosphodiesterase 5 inhibitor, KJH-1002, reverses a mouse model of amnesia by activating a cGMP/cAMP response element binding protein pathway and decreasing oxidative damage. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/29847860 | PubMed |
| 29,726,015 | Targeting the dopamine D1 receptor or its downstream signalling by inhibiting phosphodiesterase-1 improves cognitive performance. | Br J Pharmacol | 2018 | https://conductscience.org/library/papers/29726015 | PubMed |
| 29,642,004 | Cardiomyocyte Membrane Structure and cAMP Compartmentation Produce Anatomical Variation in β2AR-cAMP Responsiveness in Murine Hearts. | Cell Rep | 2018 | https://conductscience.org/library/papers/29642004 | PubMed |
| 29,123,207 | Atropine augments cardiac contractility by inhibiting cAMP-specific phosphodiesterase type 4. | Sci Rep | 2017 | https://conductscience.org/library/papers/29123207 | PubMed |
| 28,938,916 | Use of the KlADH3 promoter for the quantitative production of the murine PDE5A isoforms in the yeast Kluyveromyces lactis. | Microb Cell Fact | 2017 | https://conductscience.org/library/papers/28938916 | PubMed |
| 28,915,270 | The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target. | PLoS Negl Trop Dis | 2017 | https://conductscience.org/library/papers/28915270 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4321663
GET https://conductscience.org/api/papers/v1/4321663/cited_by?page=2